162 related articles for article (PubMed ID: 16570302)
1. Development of a respirable, sustained release microcarrier for 5-fluorouracil I: In vitro assessment of liposomes, microspheres, and lipid coated nanoparticles.
Hitzman CJ; Elmquist WF; Wattenberg LW; Wiedmann TS
J Pharm Sci; 2006 May; 95(5):1114-26. PubMed ID: 16570302
[TBL] [Abstract][Full Text] [Related]
2. Development of a respirable, sustained release microcarrier for 5-fluorouracil II: In vitro and in vivo optimization of lipid coated nanoparticles.
Hitzman CJ; Elmquist WF; Wiedmann TS
J Pharm Sci; 2006 May; 95(5):1127-43. PubMed ID: 16570303
[TBL] [Abstract][Full Text] [Related]
3. 5-Fluorouracil-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(lactide-co-glycolide) polymers: characterization and drug release.
Blanco MD; Sastre RL; Teijón C; Olmo R; Teijón JM
J Microencapsul; 2005 Sep; 22(6):671-82. PubMed ID: 16401582
[TBL] [Abstract][Full Text] [Related]
4. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers.
Sastre RL; Olmo R; Teijón C; Muñíz E; Teijón JM; Blanco MD
Int J Pharm; 2007 Jun; 338(1-2):180-90. PubMed ID: 17336474
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 5-fluorouracil in the hamster following inhalation delivery of lipid-coated nanoparticles.
Hitzman CJ; Wattenberg LW; Wiedmann TS
J Pharm Sci; 2006 Jun; 95(6):1196-211. PubMed ID: 16639722
[TBL] [Abstract][Full Text] [Related]
6. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
Leelakanok N; Geary SM; Salem AK
J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
[TBL] [Abstract][Full Text] [Related]
7. L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo.
Mishra BJ; Kaul A; Trivedi P
Drug Deliv; 2015 Feb; 22(2):214-22. PubMed ID: 24524408
[TBL] [Abstract][Full Text] [Related]
8. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J
Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485
[TBL] [Abstract][Full Text] [Related]
9. Measurement of drug release from microcarriers by microdialysis.
Hitzman CJ; Wiedmann TS; Dai H; Elmquist WF
J Pharm Sci; 2005 Jul; 94(7):1456-66. PubMed ID: 15920767
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microsphere formulations for potential combination therapy in cancer.
Hussain M; Beale G; Hughes M; Akhtar S
Int J Pharm; 2002 Mar; 234(1-2):129-38. PubMed ID: 11839444
[TBL] [Abstract][Full Text] [Related]
11. Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon.
Rai G; Yadav AK; Jain NK; Agrawal GP
Drug Deliv; 2016; 23(1):328-37. PubMed ID: 24845476
[TBL] [Abstract][Full Text] [Related]
12. Layer-by-layer assembly of poly(L-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil.
Yan S; Zhu J; Wang Z; Yin J; Zheng Y; Chen X
Eur J Pharm Biopharm; 2011 Aug; 78(3):336-45. PubMed ID: 21195174
[TBL] [Abstract][Full Text] [Related]
13. Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer.
Clares B; Biedma-Ortiz RA; Sáez-Fernández E; Prados JC; Melguizo C; Cabeza L; Ortiz R; Arias JL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):329-38. PubMed ID: 23485475
[TBL] [Abstract][Full Text] [Related]
14. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
15. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
[TBL] [Abstract][Full Text] [Related]
16. Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting.
Paharia A; Yadav AK; Rai G; Jain SK; Pancholi SS; Agrawal GP
AAPS PharmSciTech; 2007 Feb; 8(1):12. PubMed ID: 17408212
[TBL] [Abstract][Full Text] [Related]
17. Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery.
Cui LJ; Sun NX; Li XH; Huang J; Yang JG
Acta Pharmacol Sin; 2008 Sep; 29(9):1021-8. PubMed ID: 18718170
[TBL] [Abstract][Full Text] [Related]
18. Inhalable microspheres embedding chitosan-coated PLGA nanoparticles for 2-methoxyestradiol.
Guo X; Zhang X; Ye L; Zhang Y; Ding R; Hao Y; Zhao Y; Zhang Z; Zhang Y
J Drug Target; 2014 Jun; 22(5):421-7. PubMed ID: 24417740
[TBL] [Abstract][Full Text] [Related]
19. Release kinetics of 5-fluorouracil-loaded microspheres on an experimental rat glioma.
Roullin VG; Lemaire L; Venier-Julienne MC; Faisant N; Franconi F; Benoit JP
Anticancer Res; 2003; 23(1A):21-5. PubMed ID: 12680190
[TBL] [Abstract][Full Text] [Related]
20. The release of 5-fluorouracil from microspheres of poly(epsilon-caprolactone-co-ethylene oxide).
Martini LG; Collett JH; Attwood D
Drug Dev Ind Pharm; 2000 Jan; 26(1):7-12. PubMed ID: 10677804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
